https://www.biopharmawatch.com/news/CCEL/cryo-cell-fiscal-first-quarter-2026-results2026-04-14T21:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CCEL/cryo-cell-fiscal-q2-2025-results2025-07-15T21:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ABBV/abbvie-phase-1-data-abbv-295-easd-20262026-09-30T09:45:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SGMT/sagimet-positive-results-denifanstat-acne-trial2026-09-30T10:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SGMT/sagimet-biosciences-offering-115-million2026-09-30T10:19:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CMPS/compass-pathways-appoints-kelley-boucher-cpo2026-09-30T10:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HSIC/henry-schein-cares-25-years-health-happen2026-09-30T10:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ANIP/ani-pharmaceuticals-fluocinolone-acetonide-data-aao-20262026-09-30T10:55:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ANL/adlai-nortye-appoints-christopher-liu-head-investor-relations2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CNTB/connect-biopharma-announces-positive-preliminary-topline-data-global-phase-22026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/KLRA/kailera-therapeutics-kainetic-phase-3-enrollment-completed2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/JBIO/jade-biosciences-preclinical-data-jade301-dermatomyositis2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HROW/harrow-ophthalmic-portfolio-aaopt-aao-20262026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CBLL/ceribell-fda-clearance-eeg-software2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/NRXP/nrx-defense-systems-darpa-contract-evaluate-robotic-tms2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/TLSA/tiziana-life-sciences-orphan-drug-designation-intranasal-foralumab2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/OCGN/ocugen-participate-scientific-conferences2026-09-30T11:02:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CTSO/cytosorbents-new-data-presentations-conferences2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/EVGN/evogene-nasdaq-grants-180-day-compliance-period2026-09-30T11:15:00.000Zmonthly0.5https://www.biopharmawatch.com/news/WVE/gsk-selects-waves-sirna-program-for-development2026-09-30T11:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CNSY/cerenome-cnside-third-quarter-update2026-09-30T11:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CYTK/cytokinetics-launches-aspen-hcm-study-myorzo2026-09-30T11:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ABUS/arbutus-preliminary-results-tender-offer2026-09-30T11:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/IMNM/immunome-ind-clearance-im-1340-antibody-drug-conjugate2026-09-30T11:45:00.000Zmonthly0.5https://www.biopharmawatch.com/news/INKT/mink-therapeutics-arpa-h-room-temperature-cell-therapy2026-09-30T11:57:00.000Zmonthly0.5https://www.biopharmawatch.com/news/IMUX/immunic-inducement-grants-nasdaq-rule-56352026-09-29T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/PMN/upcoming-conferences-events-october-20262026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/MSLE/satellos-completes-enrollment-basecamp-phase-2-trial2026-09-30T11:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ARDX/ardelyx-honors-pm360-trailblazer-awards-20262026-09-30T12:01:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SLXN/silexion-therapeutics-announces-first-patient-successfully-dosed-phase-2-32026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/EPRX/eupraxia-phase-1b-2a-resolve-trial-data-eprx2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/IMMP/immutep-receives-rd-tax-incentive2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/VRCA/verrica-pharmaceuticals-ycanthe-data-dermatology-conferences2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/BSEM/biostem-technologies-3-million-private-placement2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/TOVX/theriva-biologics-vcn-01-virage-phase-2b-results2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/AEON/aeon-biopharma-fda-feedback-abp-450-biosimilar-development2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CELC/celcuity-revtorpyk-commercial-availability2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CADL/candel-therapeutics-aglatimagene-prostate-cancer-astro-20262026-09-30T12:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/KARD/kardigan-appoints-kristin-reinke-board-directors2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/BIAF/bioaffinity-avmedical-partnership-cypath-lung-cancer-test2026-09-30T12:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ATRA/atara-biotherapeutics-tabelecleucel-bla-resubmission2026-09-30T12:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/MRK/merck-tulisokibart-phase-2b-hidradenitis-suppurativa2026-09-30T12:15:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ERNA/ernexa-therapeutics-erna-101-safety-results-ind-studies2026-09-30T12:32:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CADL/candel-therapeutics-announces-integrated-clinical-biomarker-data-showed-durable-local2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/DCOY/decoy-therapeutics-small-cap-showcase-presentation2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LH/labcorp-third-quarter-2026-financial-results2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/NBIX/neurocrine-research-prader-willi-syndrome-vykat-xr2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/NAGE/niagen-bioscience-mass-general-brigham-clinical-trial2026-09-30T12:32:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SRPT/sarepta-elevidys-data-world-muscle-society-20262026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/DMAC/diamedica-kol-webinar-dm199-fgr-results2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/AIM/aim-immunotech-ampligen-pancreatic-cancer-therapy2026-09-30T12:44:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SILO/silo-pharma-qwikagents-ai-platform-expansion2026-09-30T12:50:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ONMD/onemednet-signs-seven-figure-agreement-ai-data-solution2026-09-30T12:55:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HYPD/hyperion-defi-launches-institutional-credit-facility2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HQY/healthequity-appoints-noemie-heuland-board-directors2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/MDT/medtronic-regulatory-milestones-cardiac-mapping-software2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ABT/abbott-third-quarter-earnings-call-20262026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/IDXX/idexx-acquires-covetai-chicago-pacific-founders-exit2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/DGX/ecg-screening-program-florida-high-school-athletes2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/BAX/baxter-connected-hospital-report-20262026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/AGL/agilon-health-jackson-clinic-partnership-aco2026-09-30T13:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SLGL/sol-gel-kol-investor-day-sgt-610-october-20262026-09-30T13:14:00.000Zmonthly0.5https://www.biopharmawatch.com/news/QTTB/q32-bio-signal-aa-trial-results-20262026-09-30T13:15:00.000Zmonthly0.5https://www.biopharmawatch.com/news/NKTR/biomarker-data-rezpegaldesleukin-atopic-dermatitis2026-09-30T14:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LNTH/lantheus-cms-grants-pylarity-truvu-status2026-09-30T12:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/NCNA/nucana-grant-patent-nuc-7738-europe2026-09-30T12:00:57.000Zmonthly0.5https://www.biopharmawatch.com/news/CELU/celularity-fontaine-vitale-opening-20272026-09-30T15:57:00.000Zmonthly0.5https://www.biopharmawatch.com/news/RVP/retractable-technologies-declares-dividends-preferred-stock2026-09-30T17:17:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HSDT/solana-company-announces-15-million-offering2026-09-30T17:57:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LQDA/liquidia-update-hatch-waxman-litigation-patent-3272026-09-30T17:20:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HCTI/healthcare-triangle-ai-humanoid-nursing-robots2026-09-30T18:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/GLUE/monte-rosa-mrt-8102-gforce-1-phase-1-results2026-09-30T20:01:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HIT/health-in-tech-launches-hitrx-modernize-health-insurance2026-09-30T20:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ABVX/abivax-obefazimod-ueg-week-20262026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LGVN/longeveron-participate-longevity-investment-conferences2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HALO/halozyme-appoints-jim-daly-board-directors2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/RDHL/redhill-biopharma-operational-highlights-h1-2026-results2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LTRN/lantern-pharma-inc-announces-closing-8-million-registered-direct-offering2026-09-30T20:01:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SCNX/scienture-holdings-reverse-stock-split2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CRVS/corvus-phase-1b-soquelitinib-hidradenitis-suppurativa2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/PLRX/pliant-therapeutics-appoints-david-raben-cmo2026-09-30T20:10:00.000Zmonthly0.5https://www.biopharmawatch.com/news/INGN/inogen-divestiture-us-oxygen-rental-business2026-09-30T20:05:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CVS/cvs-health-declares-quarterly-dividend-202609302026-09-30T20:26:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SRPT/sarepta-therapeutics-announces-inducement-grants-nasdaq-listing-rule-5635-c-202609302026-09-30T20:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/LAB/standard-biotools-update-sale-mass-cytometry-business2026-09-30T20:42:00.000Zmonthly0.5https://www.biopharmawatch.com/news/OCS/oculis-resignation-lionel-carnot-board2026-09-30T20:46:00.000Zmonthly0.5https://www.biopharmawatch.com/news/TEVA/tapi-names-serge-rogasik-ceo-growth-competitiveness2026-09-30T20:32:00.000Zmonthly0.5https://www.biopharmawatch.com/news/HCA/hca-healthcare-3q-2026-earnings-call2026-09-30T21:03:00.000Zmonthly0.5https://www.biopharmawatch.com/news/IMMX/immix-biopharma-closes-125-million-offering2026-09-30T21:15:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CLGN/collplant-reports-2026-q2-financial-results2026-09-30T21:20:00.000Zmonthly0.5https://www.biopharmawatch.com/news/DRUG/bright-minds-biosciences-fpwr-symposium-20262026-09-30T21:30:00.000Zmonthly0.5https://www.biopharmawatch.com/news/BMY/fda-approves-expanded-indication-camzyos2026-09-30T21:32:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ADIL/adial-pharmaceuticals-announces-inducement-grant-nasdaq-listing-rule-5635-c2026-09-30T21:46:00.000Zmonthly0.5https://www.biopharmawatch.com/news/PACS/pacs-post-acute-nursing-homes-20272026-09-30T22:08:00.000Zmonthly0.5https://www.biopharmawatch.com/news/ACET/adicet-bio-reports-inducement-grant-nasdaq-listing-rule-5635-c2026-09-30T23:12:00.000Zmonthly0.5https://www.biopharmawatch.com/news/UTHR/united-therapeutics-prevails-patent-litigation-liquidia2026-09-30T23:09:00.000Zmonthly0.5https://www.biopharmawatch.com/news/VCRE/increase-in-shares-and-votes-vicore-pharma2026-09-30T03:20:00.000Zmonthly0.5https://www.biopharmawatch.com/news/MRNA/moderna-coo-role-expansion-oncology2026-09-30T07:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/CUVL/clinuvel-annual-general-meeting-date2026-09-18T07:59:18.000Zmonthly0.5https://www.biopharmawatch.com/news/VBIO/valion-bio-shear-kershman-entolimod-formulation2026-09-30T07:45:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SNY/regeneron-sanofi-global-alliance-next-gen-antibodies2026-10-01T05:00:00.000Zmonthly0.5https://www.biopharmawatch.com/news/SNY/sanofi-regeneron-expand-alliance-next-generation-antibodies2026-10-01T05:00:00.000Zmonthly0.5